3 active warrant series covering 67,978,887 shares (~30.9% potential dilution); nearest expiry 2027-01-04.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $0.30 | Jan 4, 2027 96d | 17.5M | OTM | 8.0% | C$5.3M | Auto |
| warrant | $0.12 | Jun 6, 2027 249d | 44.8M | OTM | 20.4% | C$5.4M | Auto |
| warrant | $0.30 | Jan 4, 2029 827d | 5.7M | OTM | 2.6% | C$1.7M | Auto |
Basis: Current shares & price vs as-filed warrant terms.
6 option grants covering 13,571,250 shares (~6.2% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.86 | Nov 24, 2026 55d | 100K | OTM | 0.0% | C$86K | Auto |
| option | $0.65 | Jul 19, 2027 292d | 165K | OTM | 0.1% | C$107K | Auto |
| option | $0.73 | Jan 19, 2028 476d | 525K | OTM | 0.2% | C$383K | Auto |
| option | $0.60 | Mar 3, 2028 520d | 100K | OTM | 0.0% | C$60K | Auto |
| option | $0.10 | Jul 9, 2030 1378d | 12.1M | OTM | 5.5% | C$1.2M | Auto |
| option | $0.10 | May 11, 2031 1684d | 600K | OTM | 0.3% | C$60K | Auto |
219,900,970 shares outstanding, plus 67,978,887 from warrants and 13,571,250 from options — a fully diluted 301,451,107 shares, or ~37.1% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
3 active warrant series covering 67,978,887 shares (~30.9% potential dilution); nearest expiry 2027-01-04.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $0.30 | Jan 4, 2027 96d | 17.5M | OTM | 8.0% | C$5.3M | Auto |
| warrant | $0.12 | Jun 6, 2027 249d | 44.8M | OTM | 20.4% | C$5.4M | Auto |
| warrant | $0.30 | Jan 4, 2029 827d | 5.7M | OTM | 2.6% | C$1.7M | Auto |
Basis: Current shares & price vs as-filed warrant terms.
6 option grants covering 13,571,250 shares (~6.2% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.86 | Nov 24, 2026 55d | 100K | OTM | 0.0% | C$86K | Auto |
| option | $0.65 | Jul 19, 2027 292d | 165K | OTM | 0.1% | C$107K | Auto |
| option | $0.73 | Jan 19, 2028 476d | 525K | OTM | 0.2% | C$383K | Auto |
| option | $0.60 | Mar 3, 2028 520d | 100K | OTM | 0.0% | C$60K | Auto |
| option | $0.10 | Jul 9, 2030 1378d | 12.1M | OTM | 5.5% | C$1.2M | Auto |
| option | $0.10 | May 11, 2031 1684d | 600K | OTM | 0.3% | C$60K | Auto |
219,900,970 shares outstanding, plus 67,978,887 from warrants and 13,571,250 from options — a fully diluted 301,451,107 shares, or ~37.1% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
